SAHPRA REGISTERS CHINESE SINOPHARM COVID-19 VACCINE
Mon 07 February 2022: The South African Health Products Regulatory Authority (SAHPRA) announced on Monday that it has registered the MC Pharma also known as Sinopharm COVID-19 vaccine. Initially developed by the Beijing Institute of Biological Products, the local drug watchdog said the Chinese two-dose COVID-19 jab is administered at an interval of two to […]
Continue Reading
